SkinBioTherapeutics plc (AIM:SBTX)

SkinBioTherapeutics Statistics

Total Valuation

AIM:SBTX has a market cap or net worth of GBP 41.73 million. The enterprise value is 41.52 million.

Market Cap	41.73M
Enterprise Value	41.52M

Important Dates

The next estimated earnings date is Tuesday, December 2, 2025.

Earnings Date	Dec 2, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:SBTX has 258.78 million shares outstanding. The number of shares has increased by 19.79% in one year.

Current Share Class	258.78M
Shares Outstanding	258.78M
Shares Change (YoY)	+19.79%
Shares Change (QoQ)	+13.96%
Owned by Insiders (%)	17.19%
Owned by Institutions (%)	67.98%
Float	172.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.58
PB Ratio	9.30
P/TBV Ratio	176.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.12
EV / Sales	15.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.23.

Current Ratio	1.79
Quick Ratio	1.21
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-55.93

Financial Efficiency

Return on equity (ROE) is -63.28% and return on invested capital (ROIC) is -34.47%.

Return on Equity (ROE)	-63.28%
Return on Assets (ROA)	-27.75%
Return on Invested Capital (ROIC)	-34.47%
Return on Capital Employed (ROCE)	-43.56%
Revenue Per Employee	178,575
Profits Per Employee	-171,685
Employee Count	15
Asset Turnover	0.47
Inventory Turnover	2.71

Taxes

Income Tax	-24,860
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.86% in the last 52 weeks. The beta is 0.67, so AIM:SBTX's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-2.86%
50-Day Moving Average	15.25
200-Day Moving Average	18.18
Relative Strength Index (RSI)	63.88
Average Volume (20 Days)	753,906

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:SBTX had revenue of GBP 2.68 million and -2.58 million in losses. Loss per share was -0.01.

Revenue	2.68M
Gross Profit	1.49M
Operating Income	-2.55M
Pretax Income	-2.60M
Net Income	-2.58M
EBITDA	-2.31M
EBIT	-2.55M
Loss Per Share	-0.01

Balance Sheet

The company has 1.24 million in cash and 1.03 million in debt, giving a net cash position of 210,495 or 0.00 per share.

Cash & Cash Equivalents	1.24M
Total Debt	1.03M
Net Cash	210,495
Net Cash Per Share	0.00
Equity (Book Value)	4.49M
Book Value Per Share	0.02
Working Capital	1.14M

Cash Flow

Operating Cash Flow	-2.16M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 55.71%, with operating and profit margins of -95.36% and -96.14%.

Gross Margin	55.71%
Operating Margin	-95.36%
Pretax Margin	-97.07%
Profit Margin	-96.14%
EBITDA Margin	-86.20%
EBIT Margin	-95.36%
FCF Margin	n/a

Dividends & Yields

AIM:SBTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.79%
Shareholder Yield	-19.79%
Earnings Yield	-6.17%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:SBTX has an Altman Z-Score of 1.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	3